Connection
Edwin deZoeten to Infliximab
This is a "connection" page, showing publications Edwin deZoeten has written about Infliximab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.365 |
|
|
|
-
White S, Morrow R, Pan I, de Zoeten EF. Riding the Wave of Adalimumab Biosimilars: Considerations for Pediatric Gastroenterologists. J Pediatr Gastroenterol Nutr. 2023 06; 76(6):701-703.
Score: 0.205
-
de Zoeten E, Mamula P. What are the guidelines for using biologics in pediatric patients? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S259-61.
Score: 0.076
-
Constant BD, de Zoeten EF, Weinman JP, Albenberg L, Scott FI. Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children. Dig Dis Sci. 2023 03; 68(3):877-888.
Score: 0.049
-
Noel G, Diamond B, Auerbach S, de Zoeten E, Hoffenberg E. Colonic Crohn Disease After Cardiac Transplantation: Case Report and Literature Review. J Pediatr Gastroenterol Nutr. 2017 08; 65(2):e45-e46.
Score: 0.035